
Glymark-M1
Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.

Bilastine 20 mg + Montelukast 10 mg
MARST-BL is a combination tablet of Bilastine, a non-sedating second-generation antihistamine, and Montelukast, a leukotriene receptor antagonist. Together they provide comprehensive relief from allergic rhinitis, sneezing, runny nose, nasal congestion and associated bronchial symptoms.
One tablet once daily, preferably in the evening, or as directed by a registered medical practitioner.
General information only. Follow your physician's prescription.
Store at a temperature not exceeding 30°C in a cool, dry place. Protect from direct sunlight and moisture. Keep out of reach of children.
The information provided is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the guidance of a qualified physician regarding any medical condition or medication.

Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.

Glimepiride 2 mg + Metformin 500 mg (SR)
Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.

Vildagliptin 50 mg + Metformin HCl 500 mg
A DPP-4 inhibitor plus Metformin combination for comprehensive Type 2 Diabetes management.